Introduction {#section1-2324709619895165}
============

Peritonitis caused by gram-negative organisms is a significant complication encountered in patients undergoing peritoneal dialysis (PD) and is often associated with high morbidity and mortality.^[@bibr1-2324709619895165]^ *Pasteurella multocida* is an aerobic and facultative anaerobic gram-negative coccobacillus, which is a normal commensal of oropharynx of many animals but is predominant in domestic pets like cats and dogs.^[@bibr2-2324709619895165]^ It was first identified in 1878 by Perroncito and was named after Louis Pasteur in 1880 who described this bacterium in diseased birds.^[@bibr3-2324709619895165]^ This bacterium is found in the oropharynx of 30% of live stockbreeders.^[@bibr4-2324709619895165]^ Infection with bacteria is rare in humans but commonly occurs in immunocompromised patients. It is susceptible to most common antibiotics.

Case Report {#section2-2324709619895165}
===========

A 58-year-old male on PD presented to the outpatient dialysis clinic with a chief complaint of fever, abdominal pain, and cloudy effluent for 1-day duration. He denied any touch contamination. The patient has been on PD for 4 months. He has been working as a supervisor and it was a desk job. The patient denied any history of smoking, alcohol intake, or illicit drug use. The patient is married and has cats as domestic pets. The patient admitted that the cats were present in the room while he was performing PD. As per the patient, he always washed his hands while accessing PD equipment. The patient had not witnessed that the cats licked, bitten, or scratched the PD equipment. There was no leakage witnessed in the PD equipment. Past medical history is signification for polycystic kidney disease, diabetes, hypertension, hyperlipidemia, hyperparathyroidism, hypothyroidism, seizure disorder, end-stage renal disease secondary to polycystic kidney disease on PD. His home medications include atorvastatin 40 mg daily at night time, ferric citrate 210 mg one tablet 3 times a day with meals, sevelamer 800 mg 3 tablets 3 times a day with meals, omega 3 fatty acid 1 capsule daily, lactulose 20 g daily as needed for constipation, levetiracetam 500 mg twice a day, levothyroxine 100 µg daily, metoprolol 25 mg twice a day, cinacalcet 30 mg daily, and renal vitamin 1 tablet daily.

The vital signs on presentation were the temperature of 100.2°F, pulse rate of 74 beats per minute, respiratory rate of 18 breaths per minute, and blood pressure of 143/82 mm Hg. Physical examination reveals diffuse abdominal tenderness with a PD catheter in the right lower quadrant. There is neither exit site drainage nor redness along the tunnel of the catheter. The rest of the physical examination was unremarkable.

Laboratory data revealed white blood cell (WBC) count 5500/mm^3^, hemoglobin 11.3 g/dL, platelet count 260 000/mm^3^, sodium 142 mmol/L, potassium 4.2 mmol/L, bicarbonate 21 mmol/L, blood urea nitrogen 51 mg/dL, creatinine 13.8 mg/dL, and albumin 3.5 g/dL. The peritoneal fluid effluent revealed peritoneal fluid WBC 4576 cells/µL with 94% neutrophils. Peritoneal fluid gram stain revealed \>100 WBC count and no organisms seen. The patient was started on empiric treatment with intraperitoneal (IP) vancomycin and ceftazidime for peritonitis. Peritoneal fluid culture grew *P multocida* in both aerobic and anaerobic bottles. The sensitivities of *P multocida* are listed in [Table 1](#table1-2324709619895165){ref-type="table"}.

###### 

Sensitivities of *Pasteurella multocida*.

![](10.1177_2324709619895165-table1)

  Antibiotic                      Minimum Inhibitory Concentration   Sensitivity Result (S = Sensitive, R = Resistant)
  ------------------------------- ---------------------------------- ---------------------------------------------------
  Ampicillin                      0.5 µg/mL                          S
  Ceftazidime                     ≤0.03 µg/mL                        S
  Chloramphenicol                 1 µg/mL                            S
  Levofloxacin                    \<0.03 µg/mL                       S
  Penicillin                      0.25 µg/mL                         S
  Trimethoprim/sulfamethoxazole   0.25/4.75 µg/mL                    S

Antibiotic therapy subsequently tailored to IP ceftazidime as per sensitivities for 3 weeks. The repeat peritoneal fluid cultures after finishing antibiotic course yielded no bacterial growth, and the PD catheter was salvaged. The patient was counseled to prevent pets from contaminating the dialysis supplies or pets from entering the treatment room.

Discussion {#section3-2324709619895165}
==========

Peritonitis is an important and serious complication often resulting in PD catheter loss and change in dialysis modality. When the infection does not respond to the routine treatment, infection from unusual organisms should be suspected including zoonosis. There has been increased recognition of peritonitis caused by rare organisms like *P multocida*, which is related to close contact with pets.

Pets are an integral part of many households and share close bonding with the owners. Pets play a crucial role in coping with stress and provide psychological support. The close contact with the pets poses potential health risks like infections, allergies, and injuries sustained from bites, scratches, and attacks. Close contact with pets should prompt the health care provider to suspect zoonosis.^[@bibr5-2324709619895165]^

The first case of *P multocida* PD-associated peritonitis was reported in 1987.^[@bibr6-2324709619895165]^ Peritonitis from this organism has been reported infrequently but has been recognized as a significant cause. The increase in the number of cases reported might be attributed to the increased pet breeding at home. We summarized all the cases listed as *P multocida* peritonitis on literature review from PubMed in [Table 2](#table2-2324709619895165){ref-type="table"}. Cats cause most of the PD-related peritonitis from *P multocida*, accounting for more than 90%of the cases.^[@bibr2-2324709619895165]^ Mode of transmission of this zoonotic organism is through the licks, bites, and scratches of the pets.^[@bibr2-2324709619895165]^ Transmission can also be from contamination of the dialysis machine and tubes. Another possible way of transmission is hand contamination from the patient's oropharyngeal colonization of *P multocida*.^[@bibr4-2324709619895165]^

###### 

Summary of All the Cases Listed as *Pasteurella multocida* Peritonitis With Patients on Dialysis as per PubMed Review of Literature.

![](10.1177_2324709619895165-table2)

  Author                                                        Year   Age/Gender   Duration (Months)   Dialysis Mode   Leakage   Dialysate Culture   Animal Exposure        Treatment                                           Outcome
  ------------------------------------------------------------- ------ ------------ ------------------- --------------- --------- ------------------- ---------------------- --------------------------------------------------- ----------------------------
  Paul and Rostand^[@bibr6-2324709619895165]^                   1987   55/female    4                   CCPD            Present   Positive            Cat bite/scratch       Gentamicin                                          Improved
  Frankel and Cassidy^[@bibr7-2324709619895165]^                1991   55/male      15                  CAPD            Absent    Positive            Cat exposure           Gentamicin, ciprofloxacin                           Improved
  London and Bottone^[@bibr8-2324709619895165]^                 1991   54/male      6                   CCPD            Present   Positive            Cat bite               Cefazolin, gentamicin                               Improved
  Elsey et al^[@bibr9-2324709619895165]^                        1991   25/male      ≤24                 CCPD            Absent    Positive            Cat exposure           Cephradine, gentamicin                              Improved
  Kitching et al^[@bibr10-2324709619895165]^                    1996   75/male      6                   CAPD            Present   Positive            Cat bite               Cefamandole                                         Improved
  Uribarri et al^[@bibr11-2324709619895165]^                    1996   42/female    108                 CCPD            Present   Positive            Cat bite               Penicillin, gentamicin                              Improved
  Loghman-Adham^[@bibr12-2324709619895165]^                     1997   12/female    7                   CCPD            Present   Positive            Cat bite               Cephapirin, gentamicin                              Improved
  Mackay et al^[@bibr13-2324709619895165]^                      1997   73/male      12                  CAPD            Absent    Positive            Cat exposure           Ceftazidime                                         Improved
  Joh et al^[@bibr14-2324709619895165]^                         1998   55/male      12                  CCPD            Present   Positive            Cat bite               Ampicillin/sulbactam, gentamicin                    Improved
  Musio and Tiu^[@bibr15-2324709619895165]^                     1998   46/female    7                   CCPD            Absent    Positive            Cat exposure           Piperacillin, ciprofloxacin                         Improved
  Hamai et al^[@bibr16-2324709619895165]^                       1999   49/male      4                   CCPD            Present   Positive            Cat exposure           Cefazolin, tobramicin                               Improved
  Chadha and Warady^[@bibr17-2324709619895165]^                 1999   16/male      60                  CCPD            Present   Positive            Cat bite               Ticarcillin, tobramicin                             
  Van Langenhove et al^[@bibr18-2324709619895165]^              2000   22/female    12                  CCPD            Present   Positive            Cat scratch            Amikacin, ciprofloxacin                             Improved
  Martinez et al^[@bibr19-2324709619895165]^                    2000   46/female    NA                  CCPD            NA        Positive            NA                     Ceftazidime                                         NA
  Kanaan et al^[@bibr20-2324709619895165]^                      2002   24/female    7                   CCPD            Absent    Positive            Cat exposure           Ciprofloxacin                                       Improved
  Sillery et al^[@bibr21-2324709619895165]^                     2004   48/female    36                  CAPD            Absent    Positive            Cat exposure           Cefazolin, gentamicin, ampicillin                   Improved
  Cooke et al^[@bibr22-2324709619895165]^                       2004   73/female    8 and 12            CAPD            Present   Positive            Cat bite               Gentamicin, ciprofloxacin                           Improved
  Mat et al^[@bibr23-2324709619895165]^                         2005   52/male      3                   CCPD            Present   Positive            Cat exposure           Cefazolin, amikacin                                 Improved
  Malik et al^[@bibr24-2324709619895165]^                       2005   21/female    36                  CCPD            Present   Positive            Cat bite               Gentamicin, cefazolin piperacillin/tazobactam       Improved
  Malik et al^[@bibr24-2324709619895165]^                       2005   58/male      12                  CCPD            Present   Positive            Cat bite               Gentamicin                                          Improved
  Olea et al^[@bibr25-2324709619895165]^                        2006   46/female    24                  CCPD            Absent    Positive            Cat exposure           Ceftazidime                                         Improved, catheter removed
  Antony and Oglesby^[@bibr26-2324709619895165]^                2007   48/female    NA                  CAPD            Absent    Positive            Dog exposure           Cefazolin, gentamicin                               Improved
  Rondon-Berrios and Trevejo-Nunez^[@bibr4-2324709619895165]^   2010   38/male      60                  CCPD            Present   Positive            Cat exposure           Piperacillin/tazobactam, ampicillin, levofloxacin   Improved, catheter removed
  Mugambi and Ullian^[@bibr27-2324709619895165]^                2010   36/female    NA                  CCPD            Absent    Positive            Cat exposure           Gentamicin, ciprofloxacin                           Improved, catheter removed
  Satomura et al^[@bibr28-2324709619895165]^                    2010   58/male                          CCPD            Absent    Positive            Cat exposure           Cefazolin, levofloxacin                             Improved
  Nishina et al^[@bibr29-2324709619895165]^                     2011   45/male      84                  CCPD            Present   Positive            Cat exposure           Ceftazidime, levofloxacin                           Improved
  Weiss and Panesar^[@bibr30-2324709619895165]^                 2012   57/male      1                   CAPD            Absent    positive            Cat and dog exposure   Vancomycin, ceftazidime                             Improved
  Sol et al^[@bibr31-2324709619895165]^                         2013   7/female     24                  NIPD            Present   Positive            Cat exposure           Ampicillin                                          Improved
  Kim et al^[@bibr2-2324709619895165]^                          2014   25/female    24                  CAPD            Absent    Positive            Cat exposure           Cefazolin, gentamicin                               Improved
  Dresselaars et al^[@bibr32-2324709619895165]^                 2014   62/female    37                  CAPD            Absent    Positive            Cat exposure           Cefalothin, ciprofloxacin                           Improved
  Poliquin et al^[@bibr33-2324709619895165]^                    2015   28/female    1                   CAPD            Present   Positive            Cat bite               Ceftazidime                                         Improved
  Poliquin et al^[@bibr33-2324709619895165]^                    2015   37/male      15                  CAPD            Absent    Positive            Cat bite               Cefazolin                                           Improved
  Poliquin et al^[@bibr33-2324709619895165]^                    2015   41/male      18                  CAPD            NA        Positive            Cat bite               Cefazolin                                           Improved
  Poliquin et al^[@bibr33-2324709619895165]^                    2015   51/female    7                   CAPD            Absent    Positive            Cat exposure           Amoxicillin-clavulanic acid                         Improved
  Poliquin et al^[@bibr33-2324709619895165]^                    2015   37/female    132                 CAPD            Absent    Positive            Cat exposure           Ceftriaxone, amoxicillin                            Improved, catheter removed
  Poliquin et al^[@bibr33-2324709619895165]^                    2015   59/female    36                  CAPD            Absent    Positive            Cat exposure           Ceftazidime                                         Improved
  Poliquin et al^[@bibr33-2324709619895165]^                    2015   69/female    1                   CAPD            NA        Positive            Cat bite               Ceftazidime                                         Improved
  Giron et al^[@bibr34-2324709619895165]^                       2017   72/male      24                  CCPD            Present   Positive            Cat bit                Ceftazidime                                         Improved

Abbreviations: CCPD, continuous cyclic peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; NA, not available; NIPD, nocturnal intermittent peritoneal dialysis.

In an analysis of 124 patients on PD done by Broughton et al,^[@bibr5-2324709619895165]^ 12 different zoonotic organisms caused peritonitis and animals were involved in 24% of the cases. Catheter loss occurred in 27% of the patients, and the overall mortality was 24%. *Pasteurella* species peritonitis was reported in 24 patients, and cats were involved in 21 cases. Other pets involved were dogs and hamsters.^[@bibr5-2324709619895165]^

This bacterium is normal commensal in 50% to 90% of cats and 50% to 66% of the dogs in their oral cavity. It is also present in the claws of 20% of the cats.^[@bibr35-2324709619895165]^ As per Nishina et al, two thirds of the patients presented with peritonitis within 12 months of initiation of PD.^[@bibr29-2324709619895165]^ Most of the reported cases of peritonitis associated with this pathogen were due to close contact with cats or puncturing of the dialysis tubing by cats.

The bacterium is implicated in soft tissue infections, septic arthritis, pneumonia, and endocarditis in humans.^[@bibr36-2324709619895165]^ Invasive infections are more common in immunocompromised patients including cirrhosis, alcoholism, malignancy, diabetes mellitus, human immune virus deficiency infection, chronic pulmonary disease, and chronic kidney disease.^[@bibr37-2324709619895165]^ Life-threatening infections reported including infective endocarditis and sepsis.^[@bibr36-2324709619895165]^

Patients doing continuous ambulatory PD are less prone to develop peritonitis from *P multocida* compared with patients on continuous cyclic PD because of fewer chances for the pets to come in contact with the dialysis bags and tubing. The patients who had peritonitis from *P multocida* were either on continuous cyclic PD or nocturnal intermittent PD in most of the cases reported.^[@bibr2-2324709619895165],[@bibr29-2324709619895165]^ The pets, mostly cats, play with the longer dialysis tubes.^[@bibr2-2324709619895165]^ The dialysis tube trembling and the pump sound on the cycler may be an attractive toy for the cats.^[@bibr29-2324709619895165]^

Patients who are initiated on PD should be questioned about the pets they own or the intention of owning the pets. Incorporating the education on proper handling of the pets during training sessions plays a very critical role in the prevention of peritonitis from *P multocida*. Regular care of the pets, careful hand washing, proper disposal of animal waste, and placing barriers that limit the access of the pet to the dialysis equipment are the interventions that showed a significant impact on the behavior of patients toward pets. Abebe et al demonstrated this at a single dialysis center resulting in the resolution of pets-related peritonitis.^[@bibr38-2324709619895165]^ Most reported cases of peritonitis from *P multocida* mostly by contact from pets reiterates the importance of personal hygiene.

*Pasteurella multocida* peritonitis symptoms are evident as early as 24 hours with fever, cloudy effluent, and severe abdominal pain.^[@bibr4-2324709619895165]^ Dialysis cultures are usually positive, with negative gram stain and blood cultures.^[@bibr4-2324709619895165]^ *P multocida* organisms produce a characteristic mousy odor and grow on blood or chocolate agar at 37°C.^[@bibr39-2324709619895165]^ Molecular techniques like DNA sequencing and 16S rRNA gene polymerase chain reaction are used for rapid identification and characterization of *P multocida* with 16S rRNA gene polymerase chain reaction most commonly used at present.^[@bibr40-2324709619895165]^

Symptoms improve rapidly within 48 to 96 hours after initiation of treatment.^[@bibr4-2324709619895165]^ *P multocida* is susceptible to most of the antibiotics, which covers gram-negative bacteria.^[@bibr29-2324709619895165]^ The IP antibiotic treatment for 3 weeks is sufficient.^[@bibr2-2324709619895165]^ The most frequently used antibiotic is gentamicin.^[@bibr29-2324709619895165]^ *Pasteurella* can produce β-lactamases and can be penicillin resistant, and hence, ampicillin/sulbactam, amoxicillin/clavulanate, and piperacillin/tazobactam are recommended for the treatment.^[@bibr29-2324709619895165]^ There is a high likelihood of PD catheter salvage, with catheter removal in only 11% of cases. There has been no mortality reported with *P multocida* peritonitis.^[@bibr34-2324709619895165]^

Conclusion {#section4-2324709619895165}
==========

Education plays a very critical role in the prevention of peritonitis from *P multocida*, particularly if patients have pets at home. Hand washing, regular pet care, proper handling of animal waste, and adding barriers that will prevent pets from accessing the PD equipment are the potential interventions. Preventing the pets from entering the room while making connections and treatment also alleviates the risk of peritonitis from *P multocida*. Incorporating education in handing pets during the training session is a crucial aspect.
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